Prospection Blog Cracking the Code of Multi-Indication Drugs Moving Beyond Traditional Data Sources

Multi-indication drugs open new possibilities for pharmaceutical marketing but also bring unique challenges. Approved for multiple conditions, these treatments require a targeted, data-driven strategy to unlock their full potential across diverse therapeutic areas. In Japan, traditional sales and distribution data fall short in revealing specific usage patterns, risking missed opportunities and inefficient resource allocation. A more nuanced approach is essential to capture untapped potential and enhance patient access. The post Cracking the Code of Multi-Indication Drugs <br><h4>Moving Beyond Traditional Data Sources</h4> appeared first on Prospection.